Get started
Author

Erhard Quebe‐Fehling

Observed names: E Quebe-Fehling, E Quebe‐Fehling, E. Quebe-Fehling, Erhard Quebe-Fehling, Quebe-Fehling, E, Quebe-Fehling, Erhard
Observed institutions: Novartis (Switzerland), Duke University, Western General Hospital, Western Infirmary, Institut Jules Bordet, Essen University Hospital, Duke Medical Center, Institut Bergonié, Bendigo Health, Bendigo Hospital, Feist-Weiller Cancer Center, University of Duisburg-Essen, Freie Universität Berlin, Newcastle University
ORCID: 0000-0003-1507-9543
Observed ORCID: 0000-0003-1507-9543
OpenAlex ID: A5073324135
Letrozole Is More Effective Neoadjuvant Endocrine Therapy Than Tamoxifen for ErbB-1– and/or ErbB-2–Positive, Estrogen Receptor–Positive Primary Breast Cancer: Evidence From a Phase III Randomized Trial
2001 · Matthew J. Ellis, Andrew Coop, et al. · Journal of Clinical Oncology · 1,059
PDF
Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials
2001 · P. Major, A. Lortholary, et al. · Journal of Clinical Oncology · 850
Letrozole inhibits tumor proliferation more effectively than tamoxifen independent of HER1/2 expression status.
2003 · Matthew J Ellis, Andrew Coop, et al. · PubMed · 201
Prevalence and distribution of iron overload in patients with transfusion‐dependent anemias differs across geographic regions: results from the CORDELIA study
2014 · Yesim Aydinok, John B. Porter, et al. · European Journal Of Haematology · 73
A 6-month comparison between formoterol and salmeterol in patients with reversible obstructive airways disease
1998 · D. Vervloet, T. Ekström, et al. · Respiratory Medicine · 55
PDF
Darifenacin treatment for overactive bladder in patients who expressed dissatisfaction with prior extended-release antimuscarinic therapy
2008 · N. Zinner, K. C. Kobashi, et al. · International Journal of Clinical Practice · 49
Impact of baseline C-reactive protein levels on the response to secukinumab in ankylosing spondylitis: 3-year pooled data from two phase III studies
2018 · Jürgen Braun, Atul Deodhar, et al. · RMD Open · 43
PDF
Effect of Secukinumab on Traditional Cardiovascular Risk Factors and Inflammatory Biomarkers: Post Hoc Analyses of Pooled Data Across Three Indications
2022 · Joseph F. Merola, Iain B. McInnes, et al. · Rheumatology and Therapy · 42
PDF
Hormone replacement therapy and breast density changes
2005 · J Harvey, C Scheurer, et al. · Climacteric · 36
Effect of low-dose transdermal E2/NETA on the reduction of postmenopausal bone loss in women
2003 · Alessandro Rubinacci, Elena Peruzzi, et al. · Menopause The Journal of The North American Menopause Society · 33
Clinical relevance of health‐related quality of life outcomes with darifenacin
2008 · Paul Abrams, Con Kelleher, et al. · British Journal of Urology · 29
Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies
2019 · Laura C. Coates, Johan K. Wallman, et al. · Arthritis Research & Therapy · 26
PDF
Efficacy and tolerability of formoterol in elderly patients with reversible obstructive airways disease
1998 · N.C. Thomson, R. Angus, et al. · Respiratory Medicine · 23
PDF
Effects of secukinumab on bone mineral density and bone turnover biomarkers in patients with ankylosing spondylitis: 2-year data from a phase 3 study, MEASURE 1
2021 · Jürgen Braun, Bjoern Buehring, et al. · BMC Musculoskeletal Disorders · 22
PDF
Evaluation of irritation and sensitisation of two 50 μg/day oestrogen patches
2002 · John Toole, Stewart Silagy, et al. · Maturitas · 19
A prospective analysis of the incidence and prevalence of Crohnʼs disease in an urban population in Germany
1994 · Harald Goebell, Eberhard Dirks, et al. · European Journal of Gastroenterology & Hepatology · 18
[Prospective study of the incidence and prevalence of ulcerative colitis in a large urban population in Germany (western Ruhr area)].
1994 · E Dirks, S Förster, et al. · PubMed · 18
Long-term safety and efficacy of gabapentin (neurontin) as add-on therapy in patients with refractory partial seizures
1995 · Henning Anhut, Philip J Ashman, et al. · Journal of Epilepsy · 16
Achievement of Remission Endpoints with Secukinumab Over 3 Years in Active Ankylosing Spondylitis: Pooled Analysis of Two Phase 3 Studies
2020 · Xenofon Baraliakos, Filip Van den Bosch, et al. · Rheumatology and Therapy · 15
PDF
The Duration of Action of Inhaled Formoterol Dry Powder
1996 · E Quebe‐Fehling, R Brambilla, et al. · International Journal of Clinical Practice · 15
Secukinumab provides sustained improvement in nail psoriasis, signs and symptoms of psoriatic arthritis and low rate of radiographic progression in patients with concomitant nail involvement: 2-year results from the Phase III FUTURE 5 study
2021 · Peter Nash, Philip J. Mease, et al. · Clinical and Experimental Rheumatology · 13
Dose proportionality study of four doses of an estradiol transdermal system, Estradot®
2003 · M. Hossain, Erhard Quebe-Fehling, et al. · Maturitas · 11
Comparative study to evaluate skin irritation and adhesion of Estradot® and Climara® in healthy postmenopausal women
2002 · P. Ibarra de Palacios, G. Schmidt, et al. · Climacteric · 10
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials
2021 · Maxime Dougados, Uta Kiltz, et al. · Rheumatology International · 7
Hepatobiliary and Thromboembolic Events during Long-Term E.X.T.E.N.Ded Treatment with Eltrombopag in Adult Patients with Chronic Immune Thrombocytopenia (ITP)
2016 · Mansoor N. Saleh, James B Bussel, et al. · Blood · 7
Works count: 72
Citation count: 2,750
H-index: 17
I10-index: 23
Year
Topic
Type